MEDTRONIC FABRICATION : revenue, balance sheet and financial ratios

MEDTRONIC FABRICATION is a French company founded 21 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in FOURMIES (59610), this company of category ETI shows in 2025 a revenue of 10.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - MEDTRONIC FABRICATION (SIREN 482077518)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 10 219 684 € 8 613 122 € 12 830 743 € 9 875 182 € 8 094 422 € 11 210 741 € 9 096 146 € 7 496 472 € 7 479 235 € 11 479 502 €
Net income 1 044 059 € 447 918 € 621 537 € 352 577 € 372 892 € 506 415 € 543 675 € 357 049 € 383 927 € 683 086 €
EBITDA 1 534 643 € 687 687 € 997 148 € 425 863 € 910 267 € 888 206 € 623 868 € 1 040 513 € 698 324 € 979 380 €
Net margin 10.2% 5.2% 4.8% 3.6% 4.6% 4.5% 6.0% 4.8% 5.1% 6.0%

Revenue and income statement

In 2025, MEDTRONIC FABRICATION achieves revenue of 10.2 M€. Activity remains stable over the period (CAGR: -1.3%). Vs 2024, growth of +19% (8.6 M€ -> 10.2 M€). After deducting consumption (4.1 M€), gross margin stands at 6.1 M€, i.e. a rate of 60%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 1.5 M€, representing 15.0% of revenue. Positive scissor effect: EBITDA margin improves by +7.0 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 1.0 M€, i.e. 10.2% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2025) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

10 219 684 €

Gross margin (2025) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

6 141 434 €

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

1 534 643 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

1 306 389 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

1 044 059 €

EBITDA margin (2025) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

15.0%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 37%. The balance between equity and debt is satisfactory. Cash flow represents 13.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

37.45%

Cash flow / Revenue (2025) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

13.396%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.0

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

39.9%

Solvency indicators evolution
MEDTRONIC FABRICATION

Sector positioning

Debt ratio
0.0 2025
2023
2024
2025
Q1: 5.49
Med: 17.07
Q3: 41.92
Excellent

In 2025, the debt ratio of MEDTRONIC FABRICATION (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
37.45% 2025
2023
2024
2025
Q1: 36.67%
Med: 56.53%
Q3: 69.09%
Average -9 pts over 3 years

In 2025, the financial autonomy of MEDTRONIC FABRICATION (37.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
0.0 years 2025
2023
2024
2025
Q1: 0.0 years
Med: 0.66 years
Q3: 1.52 years
Excellent

In 2025, the repayment capacity of MEDTRONIC FABRICATION (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 153.79. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.3x. Danger: operating income does not cover interest charges, unsustainable situation.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

153.787

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.344

Liquidity indicators evolution
MEDTRONIC FABRICATION

Sector positioning

Liquidity ratio
153.79 2025
2023
2024
2025
Q1: 181.98
Med: 251.18
Q3: 365.98
Watch

In 2025, the liquidity ratio of MEDTRONIC FABRICATION (153.79) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
0.34x 2025
2023
2024
2025
Q1: 0.0x
Med: 0.83x
Q3: 3.14x
Average -20 pts over 3 years

In 2025, the interest coverage of MEDTRONIC FABRICATION (0.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 81 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 46 days. The gap of 35 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 44 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. WCR is negative (-101 days): operations structurally generate cash. Over 2016-2025, WCR increased by +34%, requiring additional financing.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

-2 853 029 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

81 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

46 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

44 j

WCR in days of revenue (2025) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

-101 j

WCR and payment terms evolution
MEDTRONIC FABRICATION

Positioning of MEDTRONIC FABRICATION in its sector

Comparison with sector Fabrication de matériel médico-chirurgical et dentaire

Valuation estimate

Based on 57 transactions of similar company sales (all years), the value of MEDTRONIC FABRICATION is estimated at 3 279 828 € (range 853 908€ - 6 312 424€). With an EBITDA of 1 534 643€, the sector multiple of 2.5x is applied. The price/revenue ratio is 0.23x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2025
57 tx
853k€ 3279k€ 6312k€
3 279 828 € Range: 853 908€ - 6 312 424€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
1 534 643 € × 2.5x
Estimation 3 897 011 €
765 905€ - 7 206 826€
Revenue Multiple 30%
10 219 684 € × 0.23x
Estimation 2 317 828 €
1 077 212€ - 4 849 663€
Net Income Multiple 20%
1 044 059 € × 3.0x
Estimation 3 179 870 €
738 962€ - 6 270 561€
How is this estimate calculated?

This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fabrication de matériel médico-chirurgical et dentaire)

Compare MEDTRONIC FABRICATION with other companies in the same sector:

Frequently asked questions about MEDTRONIC FABRICATION

What is the revenue of MEDTRONIC FABRICATION ?

The revenue of MEDTRONIC FABRICATION in 2025 is 10.2 M€.

Is MEDTRONIC FABRICATION profitable?

Yes, MEDTRONIC FABRICATION generated a net profit of 1.0 M€ in 2025.

Where is the headquarters of MEDTRONIC FABRICATION ?

The headquarters of MEDTRONIC FABRICATION is located in FOURMIES (59610), in the department Nord.

Where to find the tax return of MEDTRONIC FABRICATION ?

The tax return of MEDTRONIC FABRICATION is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does MEDTRONIC FABRICATION operate?

MEDTRONIC FABRICATION operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.